Navigation Links
Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
Date:9/2/2007

y years. Similarly thin brain slices from newborn rats can be cultured for weeks and are an important tool in brain biology. In the cell co-culture model now reported, these two techniques have been brought together for the first time. Brain tumour cell aggregates were labelled with fluorescent iron microparticles and grown on normal newborn rat-brain tissue slices. The double cell labelling technique allowed investigation of tumour cell invasion into brain tissue by either fluorescence or electron microscopy from the same samples. Using these techniques the tumour aggregates were found to invade the brain slices in a similar manner to tumours in the body. Having developed the model then the tumour selective uptake of nanoparticles was demonstrated in the co-culture.

The collaboration on this project has been nurtured by Professor David Walker of the School of Human Development who co-founded the Childrens Brain Tumour Research Group at Nottingham. Professor Walker said: Understanding the biology of tumours is important if we are to develop effective new treatments. This work demonstrates how close co-operation between disciplines can help to push forward ideas which could lead to new clinical therapies.

Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine, agrees with Professor Walker. Dr. Goodman stated: The convergence of cancer cell biology and nanoscience, exemplified by this study, holds great promise for the future of brain tumour therapy.


'/>"/>
Contact: Dr Martin Garnett
44-011-595-15045
University of Nottingham
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel antibiotic dressing developed for improved wound healing
3. A novel augmentation
4. Novel biopsy technique for prostate cancer
5. Novel computer model for breast cancer
6. Novel research on liver cancer
7. Novel way to fight cancer
8. Novel test for bowel cancer
9. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
10. Novel Therapy for Chronic Problem
11. Gene enchances radiation therapy - A novel approach to fight cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...ules of sugar sitting on the surface of cancer cel...med at both treating and stopping the spread of ce...clude prostate, breast, ovarian and lung, among ot...0 from the Gateway for Cancer Research, an Illinoi...ssandra Franco, M.D., Ph.D., and her co-workers at...
(Date:1/8/2009)... Allscripts Prenatal Solution Key Factor in Decisi...GO and ORLANDO, Fla., Jan. 8 /PRNewswire-FirstCall...ociates LLC, one of the largest multi-specialty gr...selected the Allscripts Enterprise(TM) Electronic ...80 physicians in 18 offices across Central Florida...
(Date:1/8/2009)...dreds of local dance students will dance to raise ...INNEAPOLIS, Jan. 8 , , , WH...rs will show off their talent in the 3rd annual Da...ted by Dance Arts Centre. The, ev... anchor., Participants raise mon...
(Date:1/8/2009)... SAN FRANCISCO, Jan. 8 M... that David Hung, M.D., president and chief,execu... Morgan Healthcare,Conference on Wednesday, Janua...t. Francis Hotel in San Francisco. , Dr. Hu...clinical,development programs for Dimebon for Alz...
Breaking Medicine News(10 mins):Health News:Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot' 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4Health News:Dance With Courage to Benefit Camp Courage 2Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2
...ts have developed a new minimally invasive method ... trials on individuals with prostate cancer soon ....le electroporation (IRE) is a result of the effort...r Rafael V. Davalos and University of California b...
...anners with standard commercial software designed ...ing coronary artery disease in as many as 40 perce..., professor in the Division of Cardiology at The U...ouston, said he discovered the abnormalities upon ...
..., a nanotechnology development company that is dev...lmonella announced today an update regarding its p...e Company stated that although it had received mul...d testing from its contract manufacturer, due to i...
...ing centre was Friday forced to call in police whe...ed overnight, demanded to be let in for the launch... that by Friday morning as many as two thousand pe...'s upmarket Landmark centre to buy the creation of...
Other Medicine News:Health News:Scientists Destroy Cancer Cells Using Electric Pulses 2Health News:Inaccuracies in Cardiac PET-CT Scanning 2Health News:Inaccuracies in Cardiac PET-CT Scanning 3Health News:NanoSensors Provides Update on Its Biosensor to Detect E.coli and Salmonella 2Health News:Designer Bag Launch Causes Shopping Chaos in Hong Kong 2
(Date:1/7/2009)...y 7 Circassia Ltd, a specialty,bi...tical care, today,announced that following succes...oleroMune(R) anti-allergy technology, the company ...er phase II clinical trial in cat allergy. The,st...0 patients with confirmed,cat allergies, and all ...
(Date:1/6/2009)...ewswire-USNewswire/ -- Sequella, Inc., a clinical-...s of epidemic potential, announced today that SQ10...berculosis (TB), was the first drug approved for e...ract to Dynport Vaccine Company LLC and Quintiles ...al Institute of Allergy and Infectious Diseases (N...
(Date:1/5/2009)...PRNewswire-FirstCall/ -- Micromet, Inc.,(Nasdaq: ...ovel, proprietary,antibodies for the treatment of...ovides an outlook on key events anticipated for th...e an update on its research and development,progr...to 16, 2009: Update on several preclinical BiTE an...
(Date:12/27/2008)...23 Warner Chilcott Limit...ts subsidiaries and Mayne Pharma International Pty...ave filed lawsuits against each of Mutual Pharmace...cals Inc. ("Mylan") and Impax Laboratories, Inc. (...f New Jersey for infringement of Mayne,s U.S. Pate...
Breaking Medicine Technology:Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3Sticky questions tackled in gecko research 1692 1Sticky questions tackled in gecko research 1692 2American Lung Association Offers Biodiesel Scholarship to Minnesota High School Seniors 8632 1Alegent com Goes Mobile 8628 1Alegent com Goes Mobile 8628 2Nick at Nite Asks Families to Kick a Bad Habit Pick a Good One in 2008 8624 1Nick at Nite Asks Families to Kick a Bad Habit Pick a Good One in 2008 8624 2Nick at Nite Asks Families to Kick a Bad Habit Pick a Good One in 2008 8624 3
... the ASCO Cancer Conference, NORTH HOLLYWOOD, Cali... International Myeloma Foundation (IMF)-supporting...pport for myeloma patients,families, researchers ...up to a Phase 3 multi- national clinical trial sho...roves the probability of,survival by 41%. The foll...
...-Agent Activity Support Development of Panzem(R),N...forme, ROCKVILLE, Md., June 05, 2007 /PRNewswire-F...rmaceutical company developing,therapeutics for th...nnounces the presentation of results of a single-a...ients with glioblastoma,multiforme (GBM). The data...
Other Medicine Technology:Study Shows Velcade Plus Doxil Improves Survival in Previously,Treated Patients With Multiple Myeloma 2Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 2Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 3Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 4
...White Sun light source offers the industry standar...o Kelvin color temperature at a lower price. A uni...Sun to be used with Olympus, Storz, ACMI/Circon an...s light output LED and re-settable bulb timer. The...
...NGAL ELISA Kit is intended for determination of hu...ine), tissue extracts or culture media., NGAL (n...atically increased, especially in urine, as early ... repair processes. NGAL expression in plasma or ur...
...Dual Light Head is clearly the favorite for most s... arms, the dual light heads rotate freely about th...nlimited positioning. Engineered construction prev...es ranging from minimally invasive through trauma ...
... configuration offers all the performance of a maj...ctly for use in Outpatient Settings, Minor Procedu...ng two single lights either side of the OR table i...hen combining Flat Screen LCD Monitors with the li...
Medicine Products: